This product is currently not cleared by the FDA and cannot be used for human clinical diagnostics. LexaGene is currently pursuing FDA Emergency Use Authorization for SARS-CoV-2 (COVID-19) testing.
MiQLab for Human Clinical Diagnostics
Obtain clinical insight in less time when critical answers matter. Rely on accurate molecular testing to improve the diagnostic and treatment process for better managed patient care.
Overview
LexaGene’s MiQLab rapid and fully automated pathogen detection system is intended to accelerate diagnostic testing to enable evidence-based treatment decisions.
This product is currently not cleared by the FDA and cannot be used for human clinical diagnostics. LexaGene is currently pursuing FDA Emergency Use Authorization for SARS-CoV-2 (COVID-19) testing.
Intended for rapid and automated pathogen detection for better patient outcomes.
Upon obtaining FDA clearance, MiQLab will allow health care professionals to rapidly identify infectious disease with actionable insights for better patient triage and care.
The MiQLab system uses real-time polymerase chain reaction (qPCR) to simultaneously screen for up to 27 targets with high sensitivity and specificity and returns results in ~2 hours.
The system is designed to expand with additional tests to meet the most urgent clinical needs.
Test under development. LexaGene is not making any express or implied claims that its product has the ability to identify, eliminate, cure or contain COVID-19 (SARS Coronavirus-2) at this time. This product is currently not cleared by the FDA and cannot be used for human clinical diagnostics. LexaGene is pursuing FDA Emergency Use Authorization for SARS-CoV-2 (COVID-19) testing.
MiQLab™ SARS-CoV-2 Test
LexaGene is currently developing a MiQLab™ SARS-CoV-2 test.
Click request for information to learn more about MiQLab™ for Clinical Diagnostics and MiQLab SARs-CoV-2 Test. These products are currently not FDA-cleared.
Resources
| Product Video |
|---|
| MiQLab Training Video |
Features and Benefits
Multiplex Detection
Simultaneously detect up to 27 pathogens and other molecular markers by real-time PCR.
Intuitive Navigation
Integrated barcode reader and convenient touchscreen simplifies data entry and results viewing.
Easy Workflow
Simply add patient sample to cartridge and load it onto MiQLab with <1 min hands-on time
Rapid Turnaround
Sample-to-answer in about 2 hours vs. waiting days for traditional culture and sensitivity test results
Automated Reporting
Wireless transfer PDF report to mobile devices, computers, and record-keeping system.
Expandable Test Menu
Designed to support growing menu of MiQLab rapid molecular tests.
MiQLab Sample-to-Answer Workflow
The MiQLab is easy to operate with a simple sample-to-answer workflow.
MiQLab Technology
This all-in-one automated system seamlessly integrates nucleic acid extraction and purification, target amplification, detection, and reporting.
